What is Enzyme (MLN)?

Deep Dive

1. Purpose & Value Proposition

Enzyme positions itself as the essential infrastructure, or "catalyst," for tokenized finance (Enzyme). Its core value is enabling institutions, asset managers, and DAOs to manage on-chain assets efficiently. The platform simplifies complex processes like fund creation, strategy execution, and cross-chain operations, aiming to bridge decentralized and traditional finance.

2. Technology & Ecosystem

The protocol operates primarily on Ethereum and offers a modular suite of products. Enzyme Blue serves as an all-in-one vault platform, while Enzyme Onyx acts as a core tech stack for wallet tokenization and building next-generation financial products (Enzyme). This allows users to structure products with diverse assets, from cryptocurrencies to real-world assets like commodities and bonds.

3. Tokenomics & Governance

MLN is a utility token required to access the Enzyme protocol. Users pay fees in MLN equivalent to 0.25% of the assets under management (AUM) linked to their vault; these tokens are automatically burned (Tokenomics | Enzyme Documentation). Up to 300,600 new MLN tokens can be minted annually to fund development and grants, governed by the Enzyme Council DAO. Future utility may include staking for governance proposals.

Conclusion

Enzyme is fundamentally a backend infrastructure provider that empowers the creation of a new, on-chain asset management industry. As tokenized finance evolves, will its modular and secure architecture become the standard for institutional-grade fund management?